75 related articles for article (PubMed ID: 24176170)
21. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
22. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
[TBL] [Abstract][Full Text] [Related]
23. Prognostic variables for cancer-related survival in node-negative colorectal carcinomas.
Di Fabio F; Nascimbeni R; Villanacci V; Baronchelli C; Bianchi D; Fabbretti G; Casella C; Salerni B
Dig Surg; 2004; 21(2):128-33. PubMed ID: 15026608
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors of survival in obstructive and non-obstructive excisable colorectal cancer].
Torres Zavala NM; Yan Quiroz EF; Burgos Chávez OA
Rev Gastroenterol Peru; 2006; 26(4):363-72. PubMed ID: 17211486
[TBL] [Abstract][Full Text] [Related]
26. Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer.
Del Vecchio Blanco G; Cretella M; Paoluzi OA; Caruso A; Mannisi E; Servadei F; Romeo S; Grasso E; Sileri P; Giannelli M; Biancone L; Palmieri G; Pallone F
Colorectal Dis; 2013 Sep; 15(9):1093-9. PubMed ID: 23627814
[TBL] [Abstract][Full Text] [Related]
27. Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer.
Min YW; Yun HS; Chang WI; Kim JY; Kim YH; Son HJ; Kim JJ; Rhee JC; Chang DK
Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):78-83. PubMed ID: 22133576
[TBL] [Abstract][Full Text] [Related]
28. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer prognosis among patients with inflammatory bowel disease.
Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
[TBL] [Abstract][Full Text] [Related]
30. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
[TBL] [Abstract][Full Text] [Related]
31. Young age is not a poor prognostic marker in colorectal cancer.
Chung YF; Eu KW; Machin D; Ho JM; Nyam DC; Leong AF; Ho YH; Seow-Choen F
Br J Surg; 1998 Sep; 85(9):1255-9. PubMed ID: 9752871
[TBL] [Abstract][Full Text] [Related]
32. Multi-organ resections for colorectal cancer: analysis of potential factors with role in the occurrence of postoperative complications and deaths.
Bartoş A; Bartoş D; Dunca F; Mocanu L; Zaharie F; Iancu M; Mironiuc A; Iancu C
Chirurgia (Bucur); 2012; 107(4):476-82. PubMed ID: 23025114
[TBL] [Abstract][Full Text] [Related]
33. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
34. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
[TBL] [Abstract][Full Text] [Related]
35. Risk factors and survival analysis of the esophageal cancer in the population of Jammu, India.
Sehgal S; Kaul S; Gupta BB; Dhar MK
Indian J Cancer; 2012; 49(2):245-50. PubMed ID: 23107978
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital.
Techawathanawanna S; Nimmannit A; Akewanlop C
J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S189-98. PubMed ID: 22574549
[TBL] [Abstract][Full Text] [Related]
37. Clinico-pathological patterns of colorectal cancer in Saudi Arabia: younger with an advanced stage presentation.
Aljebreen AM
Saudi J Gastroenterol; 2007; 13(2):84-7. PubMed ID: 19858619
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer, diabetes and survival: epidemiological insights.
Zanders MM; Vissers PA; Haak HR; van de Poll-Franse LV
Diabetes Metab; 2014 Apr; 40(2):120-7. PubMed ID: 24507584
[TBL] [Abstract][Full Text] [Related]
39. Patterns of colorectal cancer incidence, risk factors, and screening in Kentucky.
Hopenhayn C; Moore DB; Huang B; Redmond J; Tucker TC; Kryscio RJ; Boissonneault GA
South Med J; 2004 Mar; 97(3):216-23. PubMed ID: 15043326
[TBL] [Abstract][Full Text] [Related]
40. Clinical and pathological differences between early- and late-onset colorectal cancer and determinants of one-year all-cause mortality among advanced-stage patients: a retrospective cohort study in Medellín, Colombia.
Ruiz-Grajales ÁE; Orozco-Puerta MM; Zheng S; H de Bock G; Correa-Cote JC; Castrillón-Martínez E
Cancer Treat Res Commun; 2024; 39():100797. PubMed ID: 38367413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
